Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers

Wenqiang Song(Vanderbilt University), Dana M. Brantley‐Sieders(Vanderbilt University Medical Center)
Oncogene
June 5, 2017
Cited by 95


Related Papers